Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-723

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 63323-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rem02 0002 01)

FDA Label Image

Figure 1 (Rem02 0002 02)

FDA Label Image

Figure 2 (Rem02 0002 03)

Figure 2 (Rem02 0002 03)
This appears to be a table showing the mean concentration of Alfenanil and Remifentani HCI at different time intervals (in minutes) for a sample size of 5. The units for concentration are in ng/mL and the units for time are minutes. However, without more context it is difficult to determine the purpose or significance of this data.*
FDA Label Image

Rem02 0002 04

FDA Label Image

Rem02 0002 05

Rem02 0002 05
Remifentanil PRX723103 Hydrochloride 0 for Injection is an intravenous medication used for pain management. The vial contains 1 mg of remifentanil equivalent to 1 mg of hydrochloride. It should be reconstituted and diluted before use. Manufactured by Fresenius Kabi, it is a prescription-only medication. Lot/expiration number is 403600.*
FDA Label Image

Rem02 0002 06

Rem02 0002 06
Remifentanil Hydrochloride for Injection is a medication that is stored at 2°C to 25°C (36°F to 77°F) and should be discarded if unused. Before administration, it should be diluted to a concentration of 350 to 500 µg/mL. Each vial contains 1 mg of remifentanil, which can be obtained by reconstituting the solution with 1 mL of fluid per mg of remifentanil and shaking well. The solution contains approximately 1 mg of remifentanil activity per 1 mL when reconstituted as directed. It is for intravenous administration only. The inactive ingredients are 15 mg of glycine and racemic acid to adjust the pH of the solution to approximately 3 after reconstitution.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.